Permalink to Gilead paid $178 million to doctors to promote Hepatitis C drugs despite patient deaths

Gilead paid $178 million to doctors to promote Hepatitis C drugs despite patient deaths

American pharmaceutical giant Gilead has paid at least $178 million to doctors and $81 million to hospitals in the US to promote and prescribe the company’s drugs despite cases of deaths and severe side effects. The drug-maker funded as many as 21,833 physicians in 2019 alone, according to data about Gilead payments from 2013 to 2019. Arms Watch has already revealed that at least 249 patients enrolled in the Gilead $3.3 billion Hepatitis C elimination project in Georgia have died, according to leaked documents. The cause of death of some patients has been reported as “unknown” in Gilead confidential reports. Other patients enrolled in the program have discontinued treatment due to serious adverse events. Some of them have died.